M Francoual

2.7k total citations
60 papers, 2.2k citations indexed

About

M Francoual is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, M Francoual has authored 60 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in M Francoual's work include Colorectal Cancer Treatments and Studies (18 papers), Lung Cancer Treatments and Mutations (14 papers) and HER2/EGFR in Cancer Research (13 papers). M Francoual is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Lung Cancer Treatments and Mutations (14 papers) and HER2/EGFR in Cancer Research (13 papers). M Francoual collaborates with scholars based in France, Belgium and Switzerland. M Francoual's co-authors include G. Milano, O. Dassonville, F Démard, Jean–Louis Formento, M. Schneider, J. L. Formento, Marie-Christine Étienne-Grimaldi, Patricia Formento, A. Ramaioli and J. Santini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

M Francoual

60 papers receiving 2.2k citations

Peers

M Francoual
Wendy Recant United States
M Francoual
Citations per year, relative to M Francoual M Francoual (= 1×) peers Wendy Recant

Countries citing papers authored by M Francoual

Since Specialization
Citations

This map shows the geographic impact of M Francoual's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Francoual with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Francoual more than expected).

Fields of papers citing papers by M Francoual

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Francoual. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Francoual. The network helps show where M Francoual may publish in the future.

Co-authorship network of co-authors of M Francoual

This figure shows the co-authorship network connecting the top 25 collaborators of M Francoual. A scholar is included among the top collaborators of M Francoual based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Francoual. M Francoual is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Étienne-Grimaldi, Marie-Christine, Jaafar Bennouna, M Francoual, et al.. (2011). Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5‐fluorouracil‐based therapy together with cetuximab–irinotecan. British Journal of Clinical Pharmacology. 73(5). 776–785. 32 indexed citations
2.
Étienne-Grimaldi, Marie-Christine, Patricia Formento, Armelle Degeorges, et al.. (2010). Prospective analysis of the impact of VEGF‐A gene polymorphisms on the pharmacodynamics of bevacizumab‐based therapy in metastatic breast cancer patients. British Journal of Clinical Pharmacology. 71(6). 921–928. 56 indexed citations
3.
Fischel, Jean–Louis, Patricia Formento, M Francoual, et al.. (2010). Erlotinib in Combination with Capecitabine (5'dFUR) in Resistant Pancreatic Cancer Cell Lines. Journal of Chemotherapy. 22(2). 129–133. 9 indexed citations
4.
Milano, G., Marie-Christine Étienne-Grimaldi, Laëtitia Dahan, et al.. (2008). Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer. Annals of Oncology. 19(12). 2033–2038. 30 indexed citations
5.
Magné, Nicolas, Marie-Christine Étienne-Grimaldi, L. Cals, et al.. (2007). Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU‐related toxicity. British Journal of Clinical Pharmacology. 64(2). 237–240. 30 indexed citations
6.
Francoual, M, Marie-Christine Étienne-Grimaldi, Jean–Louis Formento, et al.. (2006). EGFR in colorectal cancer: more than a simple receptor. Annals of Oncology. 17(6). 962–967. 40 indexed citations
7.
Pivot, Xavier, Nicolas Magné, Emmanuel Guardiola, et al.. (2005). Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncology. 41(3). 320–327. 39 indexed citations
8.
Étienne-Grimaldi, Marie-Christine, Sandrine Pereira, Nicolas Magné, et al.. (2005). Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients. Annals of Oncology. 16(6). 934–941. 59 indexed citations
9.
Etienne, Marie‐Christine, Jean–Louis Formento, M Chazal, et al.. (2004). Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients. Pharmacogenetics. 14(12). 785–792. 114 indexed citations
10.
Magné, Nicolas, J-L Fischel, Céline Tiffon, et al.. (2003). Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil. British Journal of Cancer. 89(3). 585–592. 66 indexed citations
11.
Ferrero, Jean-­Marc, A. Ramaioli, J. L. Formento, et al.. (2001). Epidermal growth factor receptor expression in 780 breast cancer patients: A reappraisal of the prognostic value based on an eight-year median follow-up. Annals of Oncology. 12(6). 841–846. 42 indexed citations
12.
Magné, Nicolas, Xavier Pivot, René‐Jean Bensadoun, et al.. (2001). The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy. European Journal of Cancer. 37(17). 2169–2177. 45 indexed citations
13.
Ferrero, Jean-­Marc, M C Etienne, J. L. Formento, et al.. (2000). Application of an original RT-PCR–ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients. British Journal of Cancer. 82(1). 171–177. 16 indexed citations
14.
Milano, G., et al.. (1998). A clinically applicable assay for tumoral thymidylate synthase combining reverse transcriptase–PCR and High-performance liquid chromatography. European Journal of Cancer. 34(1). 182–187. 4 indexed citations
15.
Formento, Patricia, Philippe Rostagno, Jean–Louis Formento, et al.. (1998). Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity. Biochemical Pharmacology. 56(10). 1315–1322. 60 indexed citations
16.
Romain, S, et al.. (1994). Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences. European Journal of Cancer. 30(6). 740–746. 16 indexed citations
18.
Frénay, Marc, et al.. (1991). Oestrogen and progesterone receptor status in bone biopsy specimens from patients with breast cancer. European Journal of Cancer and Clinical Oncology. 27(2). 115–118. 9 indexed citations
19.
Etienne, M C, Jean–Louis Fischel, G. Milano, et al.. (1990). Steroid receptors in human osteoblast-like cells. European Journal of Cancer and Clinical Oncology. 26(7). 807–810. 29 indexed citations
20.
Formento, Jean–Louis, M Francoual, G. Milano, et al.. (1987). HPLC micromethod for simultnaeous measurement of estradiol, progesterone, androgen and glucocorticoid receptor levels. Application to breast cancer biopsies. European Journal of Cancer and Clinical Oncology. 23(9). 1307–1314. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026